SURMOUNT-1 showed average weight loss of 21.4% at 10mg over 72 weeks
Patients eligible to enter the trial were 50 years of age or older and had established, stable, CV, cerebrovascular, peripheral artery disease, CKD or NYHA class II and III heart failure or were 60 years of age or older and had other specified risk factors for CV disease
GLP-1 users require consistent support in nutrition, movement, emotional care, and habit transformation
Common patterns we see: "I'm barely eating anything" but liquid calories (coffee drinks, alcohol, smoothies) add up "I skip meals" but snacking between meals fills the gap "I eat healthy" but portion sizes haven't actually changed What to do: Track everything you eat for one week
Munagala R, et al
Also prescribed due to diabetes